---
schema_version: "secwatch.filing_event.v1"
accession: "0001809519-23-000055"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2023-12-05T23:59:59+00:00"
generated_at: "2026-06-07T18:10:59.891870+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "medium"
source: SEC EDGAR
---

# GoodRx responds to CVS Health's new pharmacy reimbursement model, highlights existing acquisition-cost pricing

## Summary
- GoodRx already hosts discount card pricing agreements informed by acquisition cost-based pricing at CVS Pharmacy and other key retailers.
- Company plans to continue implementing acquisition cost-based approach with retail partners pursuing this model.
- Sees its hybrid pharmacy contracting strategy as well positioned for evolving reimbursement models.
- Disclosure follows CVS Health's recent announcement of a new pharmacy reimbursement formula based on drug cost plus markup and fee.

## SEC filing metadata
- accession: 0001809519-23-000055
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2023-12-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: medium
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000180951923000055/0001809519-23-000055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000180951923000055/gdrx-20231205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001809519-23-000055
- JSON: https://secwatch.observer/filing/0001809519-23-000055.json
- Plain text: https://secwatch.observer/filing/0001809519-23-000055.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.